Determinants of invasive treatment in lower extremity peripheral arterial disease

Moniek van Zitteren(St. Elisabeth Hospital), Kim G. Smolderen(Yale University), Patrick W. Vriens(University of Minnesota), W.M. de Fijter(Elisabeth-TweeSteden Ziekenhuis), Jan M.M. Heyligers(Elisabeth-TweeSteden Ziekenhuis), Gery Gerritsen(Elisabeth-TweeSteden Ziekenhuis), Maria Nooren(Elisabeth-TweeSteden Ziekenhuis), D.H. Burger(Society for Vascular Surgery)

Journal of Vascular Surgery

January 22, 2014

10.1016/j.jvs.2013.08.045

Cited by 10

Related Papers

Cardiovascular Health: The Importance of Measuring Patient-Reported Health Status

|Circulation|2013|544

In Vivo Cell Seeding With Anti-CD34 Antibodies Successfully Accelerates Endothelialization but Stimulates Intimal Hyperplasia in Porcine Arteriovenous Expanded Polytetrafluoroethylene Grafts

|Circulation|2005|298

Perioperative SARS-CoV-2 infections increase mortality, pulmonary complications, and thromboembolic events: A Dutch, multicenter, matched-cohort clinical study

|Surgery|2020|126

Costs of complications after colorectal cancer surgery in the Netherlands: Building the business case for hospitals

|European Journal of Surgical Oncology|2015|103

Randomized clinical trial of chronic pain after the transinguinal preperitoneal technique compared with Lichtenstein's method for inguinal hernia repair

|British journal of surgery|2012|85